RxDoctor Payments Data

Raymond Edwards, MD

Internal Medicine · Little Rock, ARNPI 1851371314

Payments from drug & device makers

$510in general payments, 2019–2025

Across 29 payments — averaging $17.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$133
  • Novo Nordisk$107
  • GSK$59
  • Antares Pharma, Inc.$38
  • Lilly USA, LLC$34
  • Sanofi-aventis U.S. LLC$33
  • plus $107 from 6 others

What the payments were for

  • Food & beverage$510100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$510 in reported general payments places this provider in the 60th percentile of 614 internal medicine providers in Arkansas.

See all internal medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$557,144
Medicare patients
1,575
Services billed
64,616

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide89$77,876
XareltoRivaroxaban102$77,782
EliquisApixaban62$57,562
JanuviaSitagliptin Phosphate34$37,535
FarxigaDapagliflozin Propanediol13$20,891
TradjentaLinagliptin32$18,745
Atorvastatin Calcium792$7,787
JanumetSitagliptin Phos/Metformin Hcl14$7,322
LyricaPregabalin12$7,040
Potassium Chloride301$7,036
Levothyroxine Sodium553$5,664
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide152$5,169
BelsomraSuvorexant11$4,806
SymbicortBudesonide/Formoterol Fumarate18$4,406
Celecoxib57$4,254

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$107$77,87689 claims
PfizerEliquis, Lyrica, Premarin$21$67,04586 claims
AbbVieSynthroid$133$2,14755 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 614 internal medicine providers in Arkansas.

Other internal medicine in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →